Natural Hair (UK) Zinc arginine, a 5 alpha-reductase inhibitor Alopecia and Hair loss resource center. An information site providing information to help assist people suffering from  hair loss. - Zinc as treatment for hair loss, alopecia and baldness

Natural Hair (UK)Frequently Asked Questions
Links to other SitesPrivacy Policy

Search ....  

US SITE
View your shopping cart

Dutas
Propecia
Proscar
Regaine 5%
Headway
Nizoral Shampoo
Prostaguard
Retin-A
Skinoren
Pill Cutter


Hairloss information and resources
provided
by Natural-Hair

Hair Structure and Life Cycle
Common Types of Hair Loss
Alopecia Areata
Androgenetic Alopecia
Anagen Effluvium
Self Induced Hair Loss
Scarring Alopecia
Other Types of Hair Loss
Hair Loss Treatments
Medical Treatments for Androgenetic Alopecia
Natural Treatments for Androgenetic Alopecia
Alopecia Areata Treatments
Glossary of terms
Links to other sites
E-mail Enquiries/ Comments
        
Home Inhouse Drugstore
 
 
  Zinc in the human prostate

TITLE
[Zinc in the human prostate]. Le zinc dans la prostate humaine.

AUTHOR
Larue JP; Morfin RF; Charles JF

SOURCE
J Urol (Paris) 1985; 91 (7): 463-8

LANGUAGE OF ORIGIN
French

ABSTRACT
The quantities of zinc naturally present in prostatic epithelial cells determine the human prostate to be a zinc-rich gland. Since the growth of the prostate depends on androgenic steroid hormones, interrelationships between steroids and zinc were investigated. It appears now that zinc in hyperplastic prostates is bound to cytoplasmic citrate. Metabolic homeostasia in prostatic secretory cells may be insured by inhibition of cis-aconitase by free zinc and its binding to accumulating citrate. The yields of bound zinc are decreased by androgenic steroids (testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol) which increase in turn the levels of free zinc, the uptake and the reduction of testosterone and citrate accumulation. In dedifferentiated hormono-independent neoplastic cells, there is less reduction of testosterone and a drastic decrease in zinc levels due to the sole presence of a metallothionein for binding. (AUTHOR)

MJTR: Prostate AN. Zinc AN.

MNTR: Cell Nucleus AN. Cytosol AN. English Abstract. Human. Ligands. Male. Prostatic Hyperplasia ME. Prostatic Neoplasms AN. Testosterone ME. Zinc ME. JOURNAL ARTICLE

RNUM: 0 (Ligands); 57-85-2 (Testosterone); 7440-66-6 (Zinc)

GEOT: FRANCE

IDEN: ISSN: 0248-0018. JOURNAL-CODE: IHD. ENTRY-DATE: 860312. JOURNAL-SUBSET: M. IM-DATE: 8605.

ACCE: 86113560